Healthcare resource use and costs of privately insured patients who switch, discontinue, or persist on anti-muscarinic therapy for overactive bladder
J Med Econ. 2014 Oct;17(10):741-50
Authors
Ivanova JI, Hayes-Larson E, Sorg RA, Birnbaum HG, Berner T.